- call +1-201-465-4211
- email sales@mrinsights.biz
A point-of-care (POC) test is performed at or near the site where a patient initially encounters the health care system, has a rapid turnaround time (approximately 15 min), and provides actionable information that can lead to a change in patient management.
Scope of the Report:
This report studies the Point of Care Infectious Disease market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Point of Care Infectious Disease market by product type and applications/end industries.
The global Point of Care Infectious Disease market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Point of Care Infectious Disease.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Siemens Healthineers
Trivitron Healthcare
F. Hoffmann-La Roche Ltd
Alere
Quest Diagnostics, Inc
BD & Company
Chembio Diagnostics Inc
Trinity Biotech
Cardinal Health
Bio-Rad Labs Inc.
bioMérieux SA
Thermo Fisher Scientific Inc
Sight Diagnostics Ltd.
Gene POC
Ortho-Clinical Diagnostics
OJ-Bio Ltd.
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
HIV POC
Clostridium difficile POC
HBV POC
Pneumonia or Streptococcus associated infections
Respiratory syncytial virus (RSV) POC
HPV POC
Influenza/Flu POC
HCV POC
MRSA POC
TB and drug-resistant TB POC
Market Segment by Applications, can be divided into
Hospitals
Clinics
Home
Assisted Living Healthcare Facilities
Laboratories
Others
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Point of Care Infectious Disease Market Overview
1.1 Product Overview and Scope of Point of Care Infectious Disease
1.2 Classification of Point of Care Infectious Disease by Types
1.2.1 Global Point of Care Infectious Disease Revenue Comparison by Types (2017-2023)
1.2.2 Global Point of Care Infectious Disease Revenue Market Share by Types in 2017
1.2.3 HIV POC
1.2.4 Clostridium difficile POC
1.2.5 HBV POC
1.2.6 Pneumonia or Streptococcus associated infections
1.2.7 Respiratory syncytial virus (RSV) POC
1.2.8 HPV POC
1.2.9 Influenza/Flu POC
1.2.10 HCV POC
1.2.11 MRSA POC
1.2.12 TB and drug-resistant TB POC
1.3 Global Point of Care Infectious Disease Market by Application
1.3.1 Global Point of Care Infectious Disease Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Home
1.3.5 Assisted Living Healthcare Facilities
1.3.6 Laboratories
1.3.7 Others
1.4 Global Point of Care Infectious Disease Market by Regions
1.4.1 Global Point of Care Infectious Disease Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Point of Care Infectious Disease Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Point of Care Infectious Disease Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Point of Care Infectious Disease Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Point of Care Infectious Disease Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Point of Care Infectious Disease Status and Prospect (2013-2023)
1.5 Global Market Size of Point of Care Infectious Disease (2013-2023)
2 Manufacturers Profiles
2.1 Siemens Healthineers
2.1.1 Business Overview
2.1.2 Point of Care Infectious Disease Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Siemens Healthineers Point of Care Infectious Disease Revenue, Gross Margin and Market Share (2016-2017)
2.2 Trivitron Healthcare
2.2.1 Business Overview
2.2.2 Point of Care Infectious Disease Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Trivitron Healthcare Point of Care Infectious Disease Revenue, Gross Margin and Market Share (2016-2017)
2.3 F. Hoffmann-La Roche Ltd
2.3.1 Business Overview
2.3.2 Point of Care Infectious Disease Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 F. Hoffmann-La Roche Ltd Point of Care Infectious Disease Revenue, Gross Margin and Market Share (2016-2017)
2.4 Alere
2.4.1 Business Overview
2.4.2 Point of Care Infectious Disease Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Alere Point of Care Infectious Disease Revenue, Gross Margin and Market Share (2016-2017)
2.5 Quest Diagnostics, Inc
2.5.1 Business Overview
2.5.2 Point of Care Infectious Disease Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Quest Diagnostics, Inc Point of Care Infectious Disease Revenue, Gross Margin and Market Share (2016-2017)
2.6 BD & Company
2.6.1 Business Overview
2.6.2 Point of Care Infectious Disease Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 BD & Company Point of Care Infectious Disease Revenue, Gross Margin and Market Share (2016-2017)
2.7 Chembio Diagnostics Inc
2.7.1 Business Overview
2.7.2 Point of Care Infectious Disease Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Chembio Diagnostics Inc Point of Care Infectious Disease Revenue, Gross Margin and Market Share (2016-2017)
2.8 Trinity Biotech
2.8.1 Business Overview
2.8.2 Point of Care Infectious Disease Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Trinity Biotech Point of Care Infectious Disease Revenue, Gross Margin and Market Share (2016-2017)
2.9 Cardinal Health
2.9.1 Business Overview
2.9.2 Point of Care Infectious Disease Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Cardinal Health Point of Care Infectious Disease Revenue, Gross Margin and Market Share (2016-2017)
2.10 Bio-Rad Labs Inc.
2.10.1 Business Overview
2.10.2 Point of Care Infectious Disease Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Bio-Rad Labs Inc. Point of Care Infectious Disease Revenue, Gross Margin and Market Share (2016-2017)
2.11 bioMérieux SA
2.11.1 Business Overview
2.11.2 Point of Care Infectious Disease Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 bioMérieux SA Point of Care Infectious Disease Revenue, Gross Margin and Market Share (2016-2017)
2.12 Thermo Fisher Scientific Inc
2.12.1 Business Overview
2.12.2 Point of Care Infectious Disease Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Thermo Fisher Scientific Inc Point of Care Infectious Disease Revenue, Gross Margin and Market Share (2016-2017)
2.13 Sight Diagnostics Ltd.
2.13.1 Business Overview
2.13.2 Point of Care Infectious Disease Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Sight Diagnostics Ltd. Point of Care Infectious Disease Revenue, Gross Margin and Market Share (2016-2017)
2.14 Gene POC
2.14.1 Business Overview
2.14.2 Point of Care Infectious Disease Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Gene POC Point of Care Infectious Disease Revenue, Gross Margin and Market Share (2016-2017)
2.15 Ortho-Clinical Diagnostics
2.15.1 Business Overview
2.15.2 Point of Care Infectious Disease Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Ortho-Clinical Diagnostics Point of Care Infectious Disease Revenue, Gross Margin and Market Share (2016-2017)
2.16 OJ-Bio Ltd.
2.16.1 Business Overview
2.16.2 Point of Care Infectious Disease Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 OJ-Bio Ltd. Point of Care Infectious Disease Revenue, Gross Margin and Market Share (2016-2017)
3 Global Point of Care Infectious Disease Market Competition, by Players
3.1 Global Point of Care Infectious Disease Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Point of Care Infectious Disease Players Market Share
3.2.2 Top 10 Point of Care Infectious Disease Players Market Share
3.3 Market Competition Trend
4 Global Point of Care Infectious Disease Market Size by Regions
4.1 Global Point of Care Infectious Disease Revenue and Market Share by Regions
4.2 North America Point of Care Infectious Disease Revenue and Growth Rate (2013-2018)
4.3 Europe Point of Care Infectious Disease Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Point of Care Infectious Disease Revenue and Growth Rate (2013-2018)
4.5 South America Point of Care Infectious Disease Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Point of Care Infectious Disease Revenue and Growth Rate (2013-2018)
5 North America Point of Care Infectious Disease Revenue by Countries
5.1 North America Point of Care Infectious Disease Revenue by Countries (2013-2018)
5.2 USA Point of Care Infectious Disease Revenue and Growth Rate (2013-2018)
5.3 Canada Point of Care Infectious Disease Revenue and Growth Rate (2013-2018)
5.4 Mexico Point of Care Infectious Disease Revenue and Growth Rate (2013-2018)
6 Europe Point of Care Infectious Disease Revenue by Countries
6.1 Europe Point of Care Infectious Disease Revenue by Countries (2013-2018)
6.2 Germany Point of Care Infectious Disease Revenue and Growth Rate (2013-2018)
6.3 UK Point of Care Infectious Disease Revenue and Growth Rate (2013-2018)
6.4 France Point of Care Infectious Disease Revenue and Growth Rate (2013-2018)
6.5 Russia Point of Care Infectious Disease Revenue and Growth Rate (2013-2018)
6.6 Italy Point of Care Infectious Disease Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Point of Care Infectious Disease Revenue by Countries
7.1 Asia-Pacific Point of Care Infectious Disease Revenue by Countries (2013-2018)
7.2 China Point of Care Infectious Disease Revenue and Growth Rate (2013-2018)
7.3 Japan Point of Care Infectious Disease Revenue and Growth Rate (2013-2018)
7.4 Korea Point of Care Infectious Disease Revenue and Growth Rate (2013-2018)
7.5 India Point of Care Infectious Disease Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Point of Care Infectious Disease Revenue and Growth Rate (2013-2018)
8 South America Point of Care Infectious Disease Revenue by Countries
8.1 South America Point of Care Infectious Disease Revenue by Countries (2013-2018)
8.2 Brazil Point of Care Infectious Disease Revenue and Growth Rate (2013-2018)
8.3 Argentina Point of Care Infectious Disease Revenue and Growth Rate (2013-2018)
8.4 Colombia Point of Care Infectious Disease Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Point of Care Infectious Disease by Countries
9.1 Middle East and Africa Point of Care Infectious Disease Revenue by Countries (2013-2018)
9.2 Saudi Arabia Point of Care Infectious Disease Revenue and Growth Rate (2013-2018)
9.3 UAE Point of Care Infectious Disease Revenue and Growth Rate (2013-2018)
9.4 Egypt Point of Care Infectious Disease Revenue and Growth Rate (2013-2018)
9.5 Nigeria Point of Care Infectious Disease Revenue and Growth Rate (2013-2018)
9.6 South Africa Point of Care Infectious Disease Revenue and Growth Rate (2013-2018)
10 Global Point of Care Infectious Disease Market Segment by Type
10.1 Global Point of Care Infectious Disease Revenue and Market Share by Type (2013-2018)
10.2 Global Point of Care Infectious Disease Market Forecast by Type (2018-2023)
10.3 HIV POC Revenue Growth Rate (2013-2023)
10.4 Clostridium difficile POC Revenue Growth Rate (2013-2023)
10.5 HBV POC Revenue Growth Rate (2013-2023)
10.6 Pneumonia or Streptococcus associated infections Revenue Growth Rate (2013-2023)
10.7 Respiratory syncytial virus (RSV) POC Revenue Growth Rate (2013-2023)
10.8 HPV POC Revenue Growth Rate (2013-2023)
10.9 Influenza/Flu POC Revenue Growth Rate (2013-2023)
10.10 HCV POC Revenue Growth Rate (2013-2023)
10.11 MRSA POC Revenue Growth Rate (2013-2023)
10.12 TB and drug-resistant TB POC Revenue Growth Rate (2013-2023)
11 Global Point of Care Infectious Disease Market Segment by Application
11.1 Global Point of Care Infectious Disease Revenue Market Share by Application (2013-2018)
11.2 Point of Care Infectious Disease Market Forecast by Application (2018-2023)
11.3 Hospitals Revenue Growth (2013-2018)
11.4 Clinics Revenue Growth (2013-2018)
11.5 Home Revenue Growth (2013-2018)
11.6 Assisted Living Healthcare Facilities Revenue Growth (2013-2018)
11.7 Laboratories Revenue Growth (2013-2018)
11.8 Others Revenue Growth (2013-2018)
12 Global Point of Care Infectious Disease Market Size Forecast (2018-2023)
12.1 Global Point of Care Infectious Disease Market Size Forecast (2018-2023)
12.2 Global Point of Care Infectious Disease Market Forecast by Regions (2018-2023)
12.3 North America Point of Care Infectious Disease Revenue Market Forecast (2018-2023)
12.4 Europe Point of Care Infectious Disease Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Point of Care Infectious Disease Revenue Market Forecast (2018-2023)
12.6 South America Point of Care Infectious Disease Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Point of Care Infectious Disease Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Point of Care Infectious Disease Picture
Table Product Specifications of Point of Care Infectious Disease
Table Global Point of Care Infectious Disease and Revenue (
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
